SPECIFIC COURSE OF CORONAVIRUS INFECTION IN DIFFERENT HEMODYNAMIC PHENOTYPES OF CHRONIC HEART FAILURE
Аннотация
Despite the numerous scientific researches devoted to cardiovascular diseases, the implementation of new methods of their prevention, the implementation of new methods of diagnosis and treatment, the death and disability caused by these diseases is not decreasing and it remains a medical and social problem today (Ageeva L.I. 2017).
Библиографические ссылки
Kim J, Choi SM, Lee J, et al. Effect of Renin-Angiotensin System Blockage in Patients with Acute Respiratory Distress Syndrome: A Retrospective Case Control Study. Korean J Crit Care Med. 2017;32(2):154–163. doi: https://doi.org/10.4266/kjccm.2016.00976
Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–2809. doi: https://doi.org/10.1001/jama.289.21.JOC30885
Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39(7):618–625. doi: https://doi.org/10.1111/j.1365-2362.2009.02153.x
Zhang P, Zhu L, Cai J, et al. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients with Hypertension Hospitalized With COVID-19. Circ Res. 2020;126(12):1671–1681. doi: https://doi.org/10.1161/CIRCRESAHA.120.317134
Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection. Eur Heart J. Published online April 8, 2020. doi: https://doi.org/10.1093/eurheartj/ehaa286
Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail. 2020;22(5):911–915. doi: https://doi.org/10.1002/ejhf.1828
Yao XH, Li TY, He ZC, et al. A pathological report of three COVID-19 cases by minimal invasive autopsies. Zhonghua Bing Li Xue Za Zhi. 2020;49(5):411–417. doi: https://doi.org/10.3760/cma.j.cn112151-20200312-00193
Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–422. doi: https://doi.org/10.1016/S2213-2600(20)30076-X
Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18(6):619–624. doi: https://doi.org/10.1016/s0046-8177(87)80363-5
Fung G, Luo H, Qiu Y, Yang D, McManus B. Myocarditis. Circ Res. 2016;118(3):496–514. doi: https://doi.org/10.1161/CIRCRESAHA.115.306573
Akhmerov A, Marbán E. COVID-19 and the Heart. Circ Res. 2020;126(10):1443–1455. doi: https://doi.org/10.1161/CIRCRESAHA.120.317055
Суюнов, Н. Д., Ражабова, Н. Х., Рузиев, К. Р., Нарзикулова, К. Ш.(2019). Лекарственные средства используемые при болезни характеризующейся повышенным кровяным давлением и их ценообразование. Фармацевтический журнал, 1(3), 4-12.
Суюнов, Н. Д., Ражабова, Н. Х. (2020). Ўзбекистон Республикасида рўйхатдан ўтган саратонга қарши дори воситаларининг таҳлили. Фармацевтический журнал, 1(4), 3-10.
Суюнов, Н. Д., Ражабова, Н. Х. (2021). Ўпка саратони касаллигини даволашда қўлланиладиган дори воситаларининг ассортимент таҳлили. Фармацевтический журнал, 1(4), 5-17.
Суюнов, Н. Д., Ражабова, Н. Х. (2022). Ўпка саратони билан касалланган беморларнинг тиббий карталари ретроспектив таҳлили. Фармацевтический журнал, 1(6), 21-30.
Suyunov, N. D., & Rajabova, N. X. (2023). Performance indicators of the medicines used in squamous cell lung cancer. Farmaciya (Pharmacy), 72(1), 36-48.
